Mouse version of 3q29 deletion: insights into schizophrenia/ASD pathways

Emory researchers see investigating 3q29 deletion as a way of unraveling schizophrenia’s biological and genetic Read more

B cells off the rails early in lupus

Emory scientists could discern that in people with SLE, signals driving expansion and activation are present at an earlier stage of B cell differentiation than previously Read more

Head to head narcolepsy/hypersomnia study

At the sleep research meeting in San Antonio this year, there were signs of an impending pharmaceutical arms race in the realm of narcolepsy. The big fish in a small pond, Jazz Pharmaceuticals, was preparing to market its recently FDA-approved medication: Sunosi/solriamfetol. Startup Harmony Biosciences was close behind with pitolisant, already approved in Europe. On the horizon are experimental drugs designed to more precisely target the neuropeptide deficiency in people with classic narcolepsy type 1 Read more

fetal programming

How the fetal environment affects long-term health

David Barker, MD, PhD

Why do some people, given the same apparent set of risk factors, develop certain diseases and others do not? British scientist David Baker, MD, PhD, is examining this question from a unique perspective.

Barker, a professor of clinical epidemiology at the University of Southampton in the United Kingdom, is a pioneer in a field known as fetal programming. Fetal programming is the process in which environmental influences during prenatal development alter the body’s structures—for life.

He and other experts spoke on the fundamentals of the subject recently at the first Predicting Lifespan Health Conference at Emory University. “What we’re really looking for is just a few core mechanisms, which are linked to early human development and lead to a plethora of disorders,” says Barker.

Emerging evidence suggests that chronic diseases of adult life, including cardiovascular disease, type 2 diabetes and certain cancers, have their origin through fetal programming, explains Michelle Lampl, associate director of the Emory/Georgia Tech Predictive Health Institute. “These diseases and others are initiated by adverse influences before birth,” says Lampl.

Speakers addressed fetal programming and the placenta, long-term cardiovascular disease and kidney function in low birth-weight babies, epigenetics and immunity, as well as postnatal influences from infant diet and growth patterns.

Posted on by Robin Tricoles in Uncategorized Leave a comment